Wed. Oct 5th, 2022
Zydus Cadila gets tentative USFDA nod for generic drug The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version of Pfizer#39;#39;s Xeljanz XR tablets, Zydus Cadila said in a statement.